CTI Life Sciences Fund is one of very few Canadian life sciences VCs co-created with a major pension fund (Caisse de dépôt et placement du Québec) to rebuild Canada's biotech sector, positioning it as a semi-institutional anchor rather than a purely private structure. Despite modest fund sizes totaling about $245M, CTI is repeatedly cited by government bodies as a high-performing fund and serves as a central case study for how specialized Canadian funds can catalyze hundreds of millions in follow-on capital.